spacer
spacer

PDBsum entry 1qub

Go to PDB code: 
protein ligands links
Membrane adhesion PDB id
1qub

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
319 a.a. *
Ligands
NAG-NAG-MAN
NAG-NAG
NAG ×2
Waters ×32
* Residue conservation analysis
PDB id:
1qub
Name: Membrane adhesion
Title: Crystal structure of the glycosylated five-domain human beta2- glycoprotein i purified from blood plasma
Structure: Protein (human beta2-glycoprotein i). Chain: a. Fragment: beta2-glycoprotein i
Source: Homo sapiens. Human. Organism_taxid: 9606. Organelle: blood plasma
Biol. unit: Dimer (from PQS)
Resolution:
2.70Å     R-factor:   0.249     R-free:   0.269
Authors: B.Bouma,P.G.De Groot,J.M.H.Van Den Elsen,R.B.G.Ravelli,A.Schouten, M.J.A.Simmelink,R.H.W.M.Derksen,J.Kroon,P.Gros
Key ref:
B.Bouma et al. (1999). Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J, 18, 5166-5174. PubMed id: 10508150 DOI: 10.1093/emboj/18.19.5166
Date:
01-Jul-99     Release date:   08-Oct-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P02749  (APOH_HUMAN) -  Beta-2-glycoprotein 1 from Homo sapiens
Seq:
Struc:
345 a.a.
319 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1093/emboj/18.19.5166 EMBO J 18:5166-5174 (1999)
PubMed id: 10508150  
 
 
Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.
B.Bouma, P.G.de Groot, J.M.van den Elsen, R.B.Ravelli, A.Schouten, M.J.Simmelink, R.H.Derksen, J.Kroon, P.Gros.
 
  ABSTRACT  
 
Human beta(2)-glycoprotein I is a heavily glycosylated five-domain plasma membrane-adhesion protein, which has been implicated in blood coagulation and clearance of apoptotic bodies from the circulation. It is also the key antigen in the autoimmune disease anti-phospholipid syndrome. The crystal structure of beta(2)-glycoprotein I isolated from human plasma reveals an elongated fish-hook-like arrangement of the globular short consensus repeat domains. Half of the C-terminal fifth domain deviates strongly from the standard fold, as observed in domains one to four. This aberrant half forms a specific phospholipid-binding site. A large patch of 14 positively charged residues provides electrostatic interactions with anionic phospholipid headgroups and an exposed membrane-insertion loop yields specificity for lipid layers. The observed spatial arrangement of the five domains suggests a functional partitioning of protein adhesion and membrane adhesion over the N- and C-terminal domains, respectively, separated by glycosylated bridging domains. Coordinates are in the Protein Data Bank (accession No. 1QUB).
 
  Selected figure(s)  
 
Figure 1.
Figure 1 Structural representations of human blood plasma 2GPI revealing the extended chain of the five SCR domains. (A) Ribbon drawing of 2GPI with consecutive domains labelled I -V. N-linked glycans, as well as the position of the putative O-linked glycan, Thr130, are indicated by a ball-and-stick model. -strands are shown in red and helices in green. (B) Topology diagram of 2GPI. The central -sheets of all five domains are labelled B2(-B2")-B3-B4(-B5), the N- and C-terminal -sheets are labelled B1'-B2' and B4'-B5', the -helix and the 3/10 helix are denoted A1 and A2 and numbers of residues delimiting secondary structure elements are given. Disulfide bonds are indicated with dashed lines. The positions of N-glycosylation are given by hexagons; a diamond indicates the putative O-glycan. Horizontal dashed lines mark domain boundaries. (C) Ribbon representation of domain III of 2GPI with labelled secondary structure elements. The two fully conserved disulfide bonds are shown in yellow. (D) Ribbon representation of domain V of 2GPI with labelled secondary structure elements. The three disulfide bonds are indicated with yellow lines. The aberrant face, which contains the membrane-binding site, is located on the right-hand side.
Figure 5.
Figure 5 Binding of 2GPI to an anionic phospholipid surface. (A) Two views, related by 180° rotation, of the electrostatic potential surface of 2GPI. Domains are labelled I -V. The electrostatic potential is scaled from red for negative to blue for positive. (B) Positively charged patch on the aberrant half of domain V. The 14 residues contributing to this patch and the position of the disordered loop Ser311 -Lys317 are indicated. (C) Diagram of the proposed model for binding of 2GPI to acidic phospholipids. The positively charged patch on the surface of domain V is indicated by '+', acidic phospholipids are depicted by '-' and the putative membrane-insertion loop Ser311 -Ser -Leu -Ala -Phe -Trp -Lys317 is shown to insert into the phospholipid layer. The positions of N-glycans are indicated by hexagons and the putative site for O-linked glycosylation is indicated by a diamond.
 
  The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: EMBO J (1999, 18, 5166-5174) copyright 1999.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21089000 B.Giannakopoulos, P.Mirarabshahi, and S.A.Krilis (2011).
New insights into the biology and pathobiology of beta2-glycoprotein I.
  Curr Rheumatol Rep, 13, 90-95.  
21046294 B.de Laat, and P.G.de Groot (2011).
Autoantibodies directed against domain I of beta2-glycoprotein I.
  Curr Rheumatol Rep, 13, 70-76.  
20831445 I.Azimi, J.W.Wong, and P.J.Hogg (2011).
Control of mature protein function by allosteric disulfide bonds.
  Antioxid Redox Signal, 14, 113-126.  
  21255251 I.Dienava-Verdoold, M.G.Boon-Spijker, P.G.de Groot, H.J.Brinkman, J.Voorberg, K.Mertens, R.H.Derksen, and B.de Laat (2011).
Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity.
  J Thromb Haemost, 9, 738-747.  
19840195 M.Bohgaki, M.Matsumoto, T.Atsumi, T.Kondo, S.Yasuda, T.Horita, K.I.Nakayama, F.Okumura, S.Hatakeyama, and T.Koike (2011).
Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin.
  J Cell Mol Med, 15, 141-151.  
21365655 M.E.Bohlin, L.G.Blomberg, and N.H.Heegaard (2011).
Effects of ionic strength, temperature and conformation on affinity interactions of β₂-glycoprotein I monitored by capillary electrophoresis.
  Electrophoresis, 32, 728-737.  
21242018 R.T.Urbanus, and P.G.de Groot (2011).
Antiphospholipid antibodies--we are not quite there yet.
  Blood Rev, 25, 97.  
20462962 C.Agar, G.M.van Os, M.Mörgelin, R.R.Sprenger, J.A.Marquart, R.T.Urbanus, R.H.Derksen, J.C.Meijers, and P.G.de Groot (2010).
Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
  Blood, 116, 1336-1343.  
20223219 C.J.Lee, A.De Biasio, and N.Beglova (2010).
Mode of interaction between beta2GPI and lipoprotein receptors suggests mutually exclusive binding of beta2GPI to the receptors and anionic phospholipids.
  Structure, 18, 366-376.
PDB code: 2kri
20847215 F.H.Passam, S.Rahgozar, M.Qi, M.J.Raftery, J.W.Wong, K.Tanaka, Y.Ioannou, J.Y.Zhang, R.Gemmell, J.C.Qi, B.Giannakopoulos, W.E.Hughes, P.J.Hogg, and S.A.Krilis (2010).
Beta 2 glycoprotein I is a substrate of thiol oxidoreductases.
  Blood, 116, 1995-1997.  
20979592 F.H.Passam, S.Rahgozar, M.Qi, M.J.Raftery, J.W.Wong, K.Tanaka, Y.Ioannou, J.Y.Zhang, R.Gemmell, J.C.Qi, B.Giannakopoulos, W.E.Hughes, P.J.Hogg, and S.A.Krilis (2010).
Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1.
  J Thromb Haemost, 8, 1754-1762.  
20798241 J.H.Rand (2010).
A snappy new concept for APS.
  Blood, 116, 1193-1194.  
20071571 K.Cupelli, S.Müller, B.D.Persson, M.Jost, N.Arnberg, and T.Stehle (2010).
Structure of adenovirus type 21 knob in complex with CD46 reveals key differences in receptor contacts among species B adenoviruses.
  J Virol, 84, 3189-3200.
PDB codes: 3l88 3l89
19562524 M.Blank, and Y.Shoenfeld (2010).
Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome.
  Clin Rev Allergy Immunol, 38, 141-147.  
19805618 M.P.Sikara, J.G.Routsias, M.Samiotaki, G.Panayotou, H.M.Moutsopoulos, and P.G.Vlachoyiannopoulos (2010).
{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.
  Blood, 115, 713-723.  
20440842 N.Pozzi, A.Banzato, S.Bettin, E.Bison, V.Pengo, and V.De Filippis (2010).
Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of beta2-glycoprotein I.
  Protein Sci, 19, 1065-1078.  
20638238 P.G.Vlachoyiannopoulos, and J.G.Routsias (2010).
A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
  J Autoimmun, 35, 248-255.  
20551379 Y.Ioannou, J.Y.Zhang, F.H.Passam, S.Rahgozar, J.C.Qi, B.Giannakopoulos, M.Qi, P.Yu, D.M.Yu, P.J.Hogg, and S.A.Krilis (2010).
Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury.
  Blood, 116, 1961-1970.  
19676115 D.Beglov, C.J.Lee, A.De Biasio, D.Kozakov, R.Brenke, S.Vajda, and N.Beglova (2009).
Structural insights into recognition of beta2-glycoprotein I by the lipoprotein receptors.
  Proteins, 77, 940-949.  
19503104 J.Wu, Y.Q.Wu, D.Ricklin, B.J.Janssen, J.D.Lambris, and P.Gros (2009).
Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
  Nat Immunol, 10, 728-733.
PDB code: 2wii
18625445 E.Matsuura, G.R.Hughes, and M.A.Khamashta (2008).
Oxidation of LDL and its clinical implication.
  Autoimmun Rev, 7, 558-566.  
18230366 H.Mehdi, A.Naqvi, and M.I.Kamboh (2008).
Recombinant hepatitis B surface antigen and anionic phospholipids share a binding region in the fifth domain of beta2-glycoprotein I (apolipoprotein H).
  Biochim Biophys Acta, 1782, 163-168.  
18434316 J.D.Burman, E.Leung, K.L.Atkins, M.N.O'Seaghdha, L.Lango, P.Bernadó, S.Bagby, D.I.Svergun, T.J.Foster, D.E.Isenman, and J.M.van den Elsen (2008).
Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus.
  J Biol Chem, 283, 17579-17593.  
18577708 J.H.Rand, X.X.Wu, A.S.Quinn, P.P.Chen, J.J.Hathcock, and D.J.Taatjes (2008).
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.
  Blood, 112, 1687-1695.  
18188552 J.Urbanija, B.Babnik, M.Frank, N.Tomsic, B.Rozman, V.Kralj-Iglic, and A.Iglic (2008).
Attachment of beta 2-glycoprotein I to negatively charged liposomes may prevent the release of daughter vesicles from the parent membrane.
  Eur Biophys J, 37, 1085-1095.  
17964017 R.T.Urbanus, R.H.Derksen, and P.G.de Groot (2008).
Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.
  Blood Rev, 22, 93.  
18073216 S.N.Maiti, K.Balasubramanian, J.A.Ramoth, and A.J.Schroit (2008).
Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members.
  J Biol Chem, 283, 3761-3766.  
17894013 I.Krause, M.Blank, R.Cervera, J.Font, T.Matthias, S.Pfeiffer, I.Wies, A.Fraser, and Y.Shoenfeld (2007).
Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndrome.
  Ann N Y Acad Sci, 1108, 481-488.  
  18024621 J.H.Rand (2007).
The antiphospholipid syndrome.
  Hematology Am Soc Hematol Educ Program, 2007, 136-142.  
17894014 K.Kobayashi, L.R.Lopez, and E.Matsuura (2007).
Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
  Ann N Y Acad Sci, 1108, 489-496.  
17096706 M.T.Pennings, R.H.Derksen, M.van Lummel, J.Adelmeijer, K.VanHoorelbeke, R.T.Urbanus, T.Lisman, and P.G.de Groot (2007).
Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2'.
  J Thromb Haemost, 5, 369-377.  
17894016 N.Di Simone, M.P.Luigi, D.Marco, D.N.Fiorella, D.Silvia, D.M.Clara, and C.Alessandro (2007).
Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature.
  Ann N Y Acad Sci, 1108, 505-514.  
17854747 S.Sodin-Semrl, and B.Rozman (2007).
Beta2-glycoprotein I and its clinical significance: from gene sequence to protein levels.
  Autoimmun Rev, 6, 547-552.  
17826950 T.Kajiwara, T.Yasuda, and E.Matsuura (2007).
Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
  J Autoimmun, 29, 164-173.  
17265473 T.Koike, and T.Atsumi (2007).
"Resurrection of thrombin" in the pathophysiology of the antiphospholipid syndrome.
  Arthritis Rheum, 56, 393-394.  
  17872974 T.Sakai, K.Balasubramanian, S.Maiti, J.B.Halder, and A.J.Schroit (2007).
Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.
  Am J Pathol, 171, 1659-1669.  
17195232 Y.Ioannou, C.Pericleous, I.Giles, D.S.Latchman, D.A.Isenberg, and A.Rahman (2007).
Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43.
  Arthritis Rheum, 56, 280-290.  
17110310 A.Ambrozic, S.Cucnik, N.Tomsic, J.Urbanija, M.Lokar, B.Babnik, B.Rozman, A.Iglic, and V.Kralj-Iglic (2006).
Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.
  Autoimmun Rev, 6, 10-15.  
16612335 C.Licht, S.Heinen, M.Józsi, I.Löschmann, R.E.Saunders, S.J.Perkins, R.Waldherr, C.Skerka, M.Kirschfink, B.Hoppe, and P.F.Zipfel (2006).
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).
  Kidney Int, 70, 42-50.  
19804088 P.G.Vlachoyiannopoulos, and M.Samarkos (2006).
Pathogenetic potential of antiphospholipid antibodies.
  Future Cardiol, 2, 303-314.  
16281287 R.E.Saunders, T.H.Goodship, P.F.Zipfel, and S.J.Perkins (2006).
An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
  Hum Mutat, 27, 21-30.  
15878739 A.Ambrozic, B.Bozic, T.Kveder, J.Majhenc, V.Arrigler, S.Svetina, and B.Rozman (2005).
Budding, vesiculation and permeabilization of phospholipid membranes-evidence for a feasible physiologic role of beta2-glycoprotein I and pathogenic actions of anti-beta2-glycoprotein I antibodies.
  Biochim Biophys Acta, 1740, 38-44.  
15843904 K.Balasubramanian, S.N.Maiti, and A.J.Schroit (2005).
Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis.
  Apoptosis, 10, 439-446.  
16126986 K.Kobayashi, L.R.Lopez, Y.Shoenfeld, and E.Matsuura (2005).
The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
  Ann N Y Acad Sci, 1051, 442-454.  
15858010 L.Aldaz-Carroll, J.C.Whitbeck, M.Ponce de Leon, H.Lou, L.Hirao, S.N.Isaacs, B.Moss, R.J.Eisenberg, and G.H.Cohen (2005).
Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
  J Virol, 79, 6260-6271.  
16091370 M.van Lummel, M.T.Pennings, R.H.Derksen, R.T.Urbanus, B.C.Lutters, N.Kaldenhoven, and P.G.de Groot (2005).
The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.
  J Biol Chem, 280, 36729-36736.  
15890686 O.Safa, C.T.Esmon, and N.L.Esmon (2005).
Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies.
  Blood, 106, 1629-1635.  
16102052 P.G.de Groot, and R.H.Derksen (2005).
Pathophysiology of the antiphospholipid syndrome.
  J Thromb Haemost, 3, 1854-1860.  
15641049 S.Yasuda, T.Atsumi, E.Matsuura, K.Kaihara, D.Yamamoto, K.Ichikawa, and T.Koike (2005).
Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
  Arthritis Rheum, 52, 212-218.  
16227153 T.Atsumi, O.Amengual, S.Yasuda, E.Matsuura, and T.Koike (2005).
Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.
  Autoimmunity, 38, 377-381.  
15522884 T.Shi, B.Giannakopoulos, G.M.Iverson, K.A.Cockerill, M.D.Linnik, and S.A.Krilis (2005).
Domain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318.
  J Biol Chem, 280, 907-912.  
15678890 S.Yasuda (2004).
[Pathogenic roles of anti-beta2-GPI antibody in patients with antiphospholipid syndrome]
  Nihon Rinsho Meneki Gakkai Kaishi, 27, 373-378.  
12905463 I.P.Giles, D.A.Isenberg, D.S.Latchman, and A.Rahman (2003).
How do antiphospholipid antibodies bind beta2-glycoprotein I?
  Arthritis Rheum, 48, 2111-2121.  
12871358 J.Arnout, and J.Vermylen (2003).
Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease.
  J Thromb Haemost, 1, 931-942.  
12414917 J.H.Rand (2003).
The antiphospholipid syndrome.
  Annu Rev Med, 54, 409-424.  
  12937161 J.H.Rand, X.X.Wu, A.S.Quinn, P.P.Chen, K.R.McCrae, E.G.Bovill, and D.J.Taatjes (2003).
Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
  Am J Pathol, 163, 1193-1200.  
12848945 M.Kuwana (2003).
Autoreactive CD4(+) T cells to beta(2)-glycoprotein I in patients with antiphospholipid syndrome.
  Autoimmun Rev, 2, 192-198.  
11955431 B.O.Smith, R.L.Mallin, M.Krych-Goldberg, X.Wang, R.E.Hauhart, K.Bromek, D.Uhrin, J.P.Atkinson, and P.N.Barlow (2002).
Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor.
  Cell, 108, 769-780.
PDB codes: 1gkg 1gkn 1gop
12187845 E.Matsuura, K.Kobayashi, J.Kasahara, T.Yasuda, H.Makino, T.Koike, and Y.Shoenfeld (2002).
Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis.
  Int Rev Immunol, 21, 51-66.  
12124280 F.Wang, X.F.Xia, and S.F.Sui (2002).
Human apolipoprotein H may have various orientations when attached to lipid layer.
  Biophys J, 83, 985-993.  
12144810 G.M.Iverson, E.Matsuura, E.J.Victoria, K.A.Cockerill, and M.D.Linnik (2002).
The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA.
  J Autoimmun, 18, 289-297.  
11823416 M.Budayova-Spano, M.Lacroix, N.M.Thielens, G.J.Arlaud, J.C.Fontecilla-Camps, and C.Gaboriaud (2002).
The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex.
  EMBO J, 21, 231-239.
PDB code: 1gpz
12065402 M.Gaudier, Y.Gaudin, and M.Knossow (2002).
Crystal structure of vesicular stomatitis virus matrix protein.
  EMBO J, 21, 2886-2892.
PDB code: 1lg7
11717440 B.A.Cocca, S.N.Seal, P.D'Agnillo, Y.M.Mueller, P.D.Katsikis, J.Rauch, M.Weigert, and M.Z.Radic (2001).
Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells.
  Proc Natl Acad Sci U S A, 98, 13826-13831.  
11207370 K.H.Murthy, S.A.Smith, V.K.Ganesh, K.W.Judge, N.Mullin, P.N.Barlow, C.M.Ogata, and G.J.Kotwal (2001).
Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans.
  Cell, 104, 301-311.
PDB codes: 1g40 1g44
11264586 M.Weik, G.Kryger, A.M.Schreurs, B.Bouma, I.Silman, J.L.Sussman, P.Gros, and J.Kroon (2001).
Solvent behaviour in flash-cooled protein crystals at cryogenic temperatures.
  Acta Crystallogr D Biol Crystallogr, 57, 566-573.  
11118556 A.T.Lee, K.Balasubramanian, and A.J.Schroit (2000).
beta(2)-glycoprotein I-dependent alterations in membrane properties.
  Biochim Biophys Acta, 1509, 475-484.  
10809787 K.Ma, R.Simantov, J.C.Zhang, R.Silverstein, K.A.Hajjar, and K.R.McCrae (2000).
High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II.
  J Biol Chem, 275, 15541-15548.  
10968921 M.D.Lockshin (2000).
Future trends for treatment of APS.
  J Autoimmun, 15, 261-264.  
10968890 P.G.de Groot G, B.Bouma, B.C.Lutters, M.J.Simmelink, R.H.Derksen, and P.Gros (2000).
Structure-function studies on beta 2-glycoprotein I.
  J Autoimmun, 15, 87-89.  
10990172 R.A.Roubey (2000).
Update on antiphospholipid antibodies.
  Curr Opin Rheumatol, 12, 374-378.  
10961583 R.A.Roubey (2000).
Antiphospholipid syndrome: antibodies and antigens.
  Curr Opin Hematol, 7, 316-320.  
10968892 T.Koike, K.Ichikawa, T.Atsumi, H.Kasahara, and E.Matsuura (2000).
Beta 2-glycoprotein I-anti-beta 2-glycoprotein I interaction.
  J Autoimmun, 15, 97.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer